International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)	B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease	Not yet recruiting	Phase 3	2026-03-17		NCT07476729

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Charite University, Berlin, Germany	188

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Acıbadem University	Istanbul	Turkey (Türkiye)	1
Charité - Universitätsmedizin Berlin	Berlin	Germany	21
CHU de NICE, Hôpital L'ARCHET	Nice	France	1
Fakultni Nemocnice V Motole	Prague	Czechia	1
Fundeni Clinical Institute, Pediatric Clinic Fundeni	Bucharest	Romania	1
Ghent University Hospital	Ghent	Belgium	3
HUS Helsinki University Hospital	Helsinki	Finland	1
Instituto Português de Oncologia de Lisboa	Lisbon	Portugal	1
Karolinska University Hospital	Solna	Sweden	5
Ospedale Pediatrico Bambino Gesu	Rome	Italy	8
Prinses Máxima Centrum	Utrecht	Netherlands	1
Rigshospitalet	Copenhagen	Denmark	141
Semmelweis University	Budapest	Hungary	2
St. Anna Kinderspital GmbH	Vienna	Austria	1
Tel Aviv Sourasky Medical Centre Dana-Dwek Children's Hospital	Tel Aviv	Israel	1
University Children's Hospital	Zurich	Switzerland	4
University Clinical Hospital Virgen De La Arrixaca	Murcia	Spain	1
University Medical Centre Ljubljana	Ljubljana	Slovenia	35
University Wroclaw	Wroclaw	Poland	1
Univerzity Komenského a Národného	Bratislava	Slovakia	1

Clinical trials